ICD-10 Coding for Acute Myeloid Leukemia(C92.0, C92.00, C92.00A)
Comprehensive guide on ICD-10 coding for acute myeloid leukemia, including remission status and documentation requirements.
Complete code families applicable to Acute Myeloid Leukemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C92.00 | Acute myeloid leukemia, not having achieved remission | Use when AML is newly diagnosed or relapsed without achieving remission. |
|
| C92.01 | Acute myeloid leukemia, in remission | Use when AML is in remission after treatment. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAcute Myeloid Leukemia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Acute Myeloid Leukemia.
Omitting genetic mutation details
Impact
Clinical: Affects treatment decisions., Regulatory: May lead to coding audits., Financial: Potential for denied claims.
Mitigation
Ensure genetic testing results are documented., Include in all relevant coding.
Incorrect remission status coding
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Misclassification may result in audits., Data Quality: Affects clinical data accuracy and patient care.
Mitigation
Verify remission status with lab results before coding.
Remission status coding
Impact
Incorrect remission status can trigger audits.
Mitigation
Ensure accurate documentation of remission status.